Literature DB >> 9597542

A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis.

D I Papac1, J B Briggs, E T Chin, A J Jones.   

Abstract

This report describes a convenient method for the rapid and efficient release of N-linked oligosaccharides from low microgram amounts of glycoproteins. A 96-well MultiScreen assay system containing a polyvinylidene difluoride (PVDF) membrane is employed to immobilize glycoproteins for subsequent enzymatic deglycosylation. Recombinant tissue-type plasminogen activator (rt-PA) is used to demonstrate the deglycosylation of 0.1-50 micrograms of a glycoprotein. This method enabled the recovery of a sufficient amount of N-linked oligosaccharides released enzymatically with peptide N-glycosidase F (PNGaseF) from as little as 0.5 microgram rt-PA for subsequent analysis by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. The immobilization of rt-PA to the PVDF membrane did not sterically inhibit the PNGaseF-mediated release of oligosaccharides from rt-PA as determined by tryptic mapping experiments. Comparison of the oligosaccharides released from 50 micrograms of rt-PA by either the 96-well plate method or by a standard solution digestion procedure showed no significant differences in the profiles obtained by high-pH anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD). Both neutral and sialylated oligosaccharide standards spiked into wells were recovered equally as determined by HPAEC-PAD. One advantage of this approach is that reduction and alkylation can be performed on submicrogram amounts of glycoproteins with easy removal of reagents prior to PNGaseF digestion. In addition, this method allows 60 glycoprotein samples to be deglycosylated in 1 day with MALDI-TOF or HPAEC-PAD analysis being performed on the following day.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597542     DOI: 10.1093/glycob/8.5.445

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  20 in total

1.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

2.  Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines.

Authors:  Esther M Yoo; Li J Yu; Letitia A Wims; David Goldberg; Sherie L Morrison
Journal:  MAbs       Date:  2010-05-17       Impact factor: 5.857

3.  Characterization of the N-linked oligosaccharides from human chorionic gonadotropin expressed in the methylotrophic yeast Pichia pastoris.

Authors:  Véronique Blanchard; Rupali A Gadkari; Gerrit J Gerwig; Bas R Leeflang; Rajan R Dighe; Johannis P Kamerling
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

4.  Cloning and characterization of the glucosidase II alpha subunit gene of Trichoderma reesei: a frameshift mutation results in the aberrant glycosylation profile of the hypercellulolytic strain Rut-C30.

Authors:  Steven Geysens; Tiina Pakula; Jaana Uusitalo; Isabelle Dewerte; Merja Penttilä; Roland Contreras
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

5.  Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris.

Authors:  Byung-Kwon Choi; Piotr Bobrowicz; Robert C Davidson; Stephen R Hamilton; David H Kung; Huijuan Li; Robert G Miele; Juergen H Nett; Stefan Wildt; Tillman U Gerngross
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

6.  A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.

Authors:  Brian Moldt; Mami Shibata-Koyama; Eva G Rakasz; Niccole Schultz; Yutaka Kanda; D Cameron Dunlop; Samantha L Finstad; Chenggang Jin; Gary Landucci; Michael D Alpert; Anne-Sophie Dugast; Paul W H I Parren; Falk Nimmerjahn; David T Evans; Galit Alter; Donald N Forthal; Jörn E Schmitz; Shigeru Iida; Pascal Poignard; David I Watkins; Ann J Hessell; Dennis R Burton
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

7.  Paracoccin from Paracoccidioides brasiliensis; purification through affinity with chitin and identification of N-acetyl-beta-D-glucosaminidase activity.

Authors:  Fausto Bruno dos Reis Almeida; Leandro Licursi de Oliveira; Marcelo Valle de Sousa; Maria Cristina Roque Barreira; Ebert Seixas Hanna
Journal:  Yeast       Date:  2010-02       Impact factor: 3.239

Review 8.  Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.

Authors:  Dusica Babovic-Vuksanovic; John F O'Brien
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation.

Authors:  Yadong Wei; Cishan Li; Wei Huang; Bing Li; Scott Strome; Lai-Xi Wang
Journal:  Biochemistry       Date:  2008-09-05       Impact factor: 3.162

10.  The effects of culture conditions on the glycosylation of secreted human placental alkaline phosphatase produced in Chinese hamster ovary cells.

Authors:  Jong Hyun Nam; Fuming Zhang; Myriam Ermonval; Robert J Linhardt; Susan T Sharfstein
Journal:  Biotechnol Bioeng       Date:  2008-08-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.